Management of Stevens-Johnson Syndrome
Initial Assessment and Treatment
- The British Journal of Dermatology recommends immediate discontinuation of the suspected culprit medication and urgent referral to a specialized burn unit or dermatology service for comprehensive care, as any mucosal involvement plus skin rash after medication exposure, blisters or skin detachment of any percentage, purpuric macules, facial swelling with mucosal symptoms, difficulty swallowing or breathing, and skin pain out of proportion to appearance are critical indicators of SJS 1
- Calculate the SCORTEN score for mortality prediction, and perform a complete assessment including documentation of all medications taken, creation of a timeline of drug exposure, and examination of all mucosal sites, as recommended by the British Journal of Dermatology 1
- The SCORTEN score parameters are summarized in the following table:
| Parameter | Points |
|---|---|
| Age >40 years | 1 |
| Heart rate >120 bpm | 1 |
| Cancer/hematological malignancy | 1 |
| Epidermal detachment >10% body surface area | 1 |
| Serum urea >10 mmol/L | 1 |
| Serum glucose >14 mmol/L | 1 |
| Serum bicarbonate <20 mmol/L | 1 |
- The predicted mortality rates based on the SCORTEN score are:
| SCORTEN Points | Predicted Mortality (%) |
|---|---|
| 0 | 1 |
| 1 | 4 |
| 2 | 12 |
| 3 | 32 |
| 4 | 62 |
| 5 | 85 |
| 6 | 95 |
| 7 | 99 |
- Document prodromal symptoms, including fever, malaise, and upper respiratory symptoms, and record date of rash onset and progression in patients with suspected severe skin conditions, as recommended by the British Journal of Dermatology guidelines 1
- Assess vital signs, oxygen saturation, and extent of skin involvement, including presence of target lesions, purpuric macules, blisters, and mucosal involvement (eyes, mouth, genitalia) in patients with suspected severe skin conditions, according to the British Journal of Dermatology guidelines 1
Medication and Treatment
- The Journal of Clinical Oncology recommends systemic corticosteroids, specifically IV methylprednisolone 0.5-1 mg/kg/day with tapering over at least 4 weeks 2
- High-risk medications for SJS/TEN include anti-epileptic drugs, antibiotics, allopurinol, NSAIDs, and nevirapine, as noted by the Journal of Allergy and Clinical Immunology 3
- Consider using intravenous immunoglobulin (IVIg) as a treatment option, although the evidence is mixed, as recommended by the British Journal of Dermatology guidelines 1
Wound Care and Supportive Measures
- Establish a multidisciplinary team coordinated by dermatology/plastic surgery, including intensive care, ophthalmology, and specialist nursing, to manage patients with severe skin conditions, according to the British Journal of Dermatology guidelines 1
- Use barrier-nurse in side room with controlled humidity, maintain ambient temperature between 25-28°C, and use pressure-relieving mattress to prevent further skin damage, as recommended by the British Journal of Dermatology guidelines 1
- Apply emollients to intact skin, and use gentle cleaning with sterile water or saline solution, and antimicrobial agents such as chlorhexidine (1/5000), according to the British Journal of Dermatology guidelines 1
- Emollients and dressings should be applied, including a greasy emollient (50% white petrolatum with 50% liquid paraffin) and non-adherent dressings (Mepitel or Telfa) on denuded areas, and secondary foam dressings to collect exudate, as recommended by the British Journal of Dermatology guidelines 1
Management of Specific Complications
- Apply non-preserved lubricants every 2 hours, consider moisture chambers for severe cases, and use broad-spectrum topical antibiotic prophylaxis for corneal fluorescein staining/ulceration to manage ocular complications, as recommended by the British Journal of Dermatology guidelines 1
- Apply white soft paraffin to lips every 2 hours, use mucoprotectant mouthwash three times daily, and clean the mouth daily with warm saline mouthwashes to manage oral complications, according to the British Journal of Dermatology guidelines 1
- Apply white soft paraffin every 4 hours, use Mepitel dressings for eroded areas, and consider dilator/tampon wrapped in Mepitel for the vagina to prevent synechiae, as recommended by the British Journal of Dermatology guidelines 1
- Monitor for pulmonary complications, which can indicate disease severity, and be vigilant for bronchial epithelial necrolysis, which may cause sudden airway obstruction, according to the British Journal of Dermatology guidelines 1
Follow-up and Prevention
- Arrange ophthalmology follow-up within weeks of discharge if eye involvement occurred, and dermatology follow-up within 4-6 weeks, as well as documenting the causative drug and providing patient with information, as recommended by the British Journal of Dermatology guidelines 1
- Patients should be provided with documentation of the causative drug to avoid future exposure, and consideration should be given to a MedicAlert bracelet, according to the British Journal of Dermatology guidelines 1
- Arrange follow-up with dermatology within 4-6 weeks, and consider MedicAlert bracelet/amulet to prevent future exposure to the culprit drug, as recommended by the British Journal of Dermatology guidelines 1, 4
- Monitor for long-term sequelae, particularly ocular complications, as recommended by the British Journal of Dermatology guidelines 1
- The British Journal of Dermatology recommends against routine drug hypersensitivity testing following an episode of severe skin conditions, but suggests that in vitro tests such as lymphocyte drug-induced IFN-γ assay and drug-induced lymphocyte cytokine production tests may be considered in specific cases where the culprit drug cannot be identified with confidence 1